Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Promedior, Inc

+1 (781) 538-4200
Website

Advertisement

Advertisement

1 DNA Way Ste 105
South San Francisco, CA 94080
+1 (781) 538-4200
https://www.roche.com

Promedior, Inc is a biotechnology company based in South San Francisco, CA, specializing in the development of novel therapeutics for fibrotic diseases.

The company focuses on advancing innovative treatments that target the underlying mechanisms of fibrosis to address unmet medical needs in patients.

Generated from their business information

Also at this address

Bohen, Sean P MD

Lee, June H K MD

Semba, Charles P MD

Schutzman, Jennifer L MD

Find related places

Pharmacy

Pharmacy

Own this business?
Claim it
See a problem?

You might also like

NovaBay Pharmaceuticals, Inc.
Testing laboratories, Drugs acting on the respiratory system, Drugs and drug proprietaries

NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals is a clinical stage biopharmaceutical company that develops nonantibiotic, antimicrobial products. Its products target the treatment and prevention of a range of infections in hospitals. It has entered into a licensing and research collaboration agreement with an affiliate of Alcon Incorporated for use of the Aganocide compounds for eyes, ears and sinus and in contact lens solutions. Its products include Aganocide, AgaDerm, AgaNase, and NeutroPhase. The company conducts in vitro and in vivo tests on its compounds that kill a range of bacteria, viruses and infection-causing microbes. NovaBay Pharmaceuticals also offers products for ventilator associated pneumonia, central venous catheter infections, and dialysis access associated infections. The company works in partnership with Kinetic Concepts, which is a medical technology company in the United States that provides advanced wound care and therapeutic services.
Drugs acting on the respiratory system, Blood derivatives

Scios Inc

Services, nec, nec, Blood derivatives, Testing laboratories

Sangamo Biosciences

Sangamo BioSciences, founded in 1995 and located in Richmond, Calif., is focused on the research and development of novel transcription factors for the regulation of gene expression. The company s most advanced therapeutic development program involves the use of transcription factors for the treatment of cardiovascular disease. Its other therapeutics development programs are focused on cancer, neuropathic pain, ophthalmic and infectious diseases. Sangamo s proprietary technology enables the engineering of transcription factors known as zinc finger DNA binding proteins. By engineering ZFPs so that they can recognize a specific gene, Sangamo has created ZFP transcription factors that can control gene expression and cell function. The company is developing ZFP TFs as a fundamentally enabling technology for commercial applications in human therapeutics, pharmaceutical discovery, agriculture and industrial biotechnology. More than 20 leading pharmaceutical and biotechnology companies have utilized Sangamo s research. The company trades on NASDAQ under the symbol SGMO.
United States›California›South San Francisco›Promedior, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell